Streptozotocin Diabetes Attenuates the Effects of Nondepolarizing Neuromuscular Relaxants on Rat Muscles

Lina HUANG; Dan CHEN; Shitong LI; Lina HUANG; Dan CHEN; Shitong LI; Lina HUANG; Dan CHEN; Shitong LI.
The Korean Journal of Physiology and Pharmacology ; : 461-467, 2014.
Artículo en Inglés | WPRIM | ID: wpr-727699

Documentos relacionados

  1. Encapsulation Dynamics of Neuromuscular Blocking Drugs by Sugammadex.
  2. Analysis of the factors contributing to residual weakness after sugammadex administration in pediatric patients under 2 years of age.
  3. Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents: beware of the risks.
  4. Sugammadex: A Limited But Important Role in Emergency Medicine.
  5. Erroneous neuraxial administration of neuromuscular blocking drugs: Clinical and human factors analysis.
  6. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
  7. Pillar[6]MaxQ functions as an <i>in vivo</i> sequestrant for rocuronium and vecuronium.
  8. Effects of neuromuscular blocking drugs on viability of human umbilical vein endothelial cells (HUVECs).
  9. Effect of neuromuscular blockade on the bispectral index in critically ill patients.
  10. Recovery from neuromuscular block in dogs: restoration of spontaneous ventilation does not exclude residual blockade.